2023
DOI: 10.1007/s43440-023-00506-z
|View full text |Cite
|
Sign up to set email alerts
|

Secondary fungal infections in SARS-CoV-2 patients: pathological whereabouts, cautionary measures, and steadfast treatments

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 207 publications
0
1
0
Order By: Relevance
“…The fungal infections, either as a secondary or preexisting state, aggravated the mortality during the COVID-19 pandemic. Besides increasing epidemiological awareness, pathogenesis and management of these fungal infections, fungal diseases using medicinal remedies, including Amphotericin B have been reported (Singh et al, 2023). The study of medicinal plants as potential antifungal agents against human pathogenic fungi is a promising area of research.…”
Section: Discussionmentioning
confidence: 99%
“…The fungal infections, either as a secondary or preexisting state, aggravated the mortality during the COVID-19 pandemic. Besides increasing epidemiological awareness, pathogenesis and management of these fungal infections, fungal diseases using medicinal remedies, including Amphotericin B have been reported (Singh et al, 2023). The study of medicinal plants as potential antifungal agents against human pathogenic fungi is a promising area of research.…”
Section: Discussionmentioning
confidence: 99%